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Cerebrovascular accidents and coronary artery disease are the leading causes of cardiovascular mortalities 
in Brazil and high levels of LDL cholesterol are one of the main risk factors. In this context, several 
plant extracts and natural substances have shown promise as cholesterol-lowering. The objective of 
this study was to evaluate the potential of the hydroalcoholic extract of the fruit of H. dulcis and of 
dihydromyricetin in cholesterol reduction in hypercholesterolemic rats. Forty-two Wistar male rats were 
distributed into seven groups of six animals that received diets supplemented with 1% cholesterol and 
0.3% cholic acid, with the exception of the control group, which received conventional diets. Animals 
were treated with oral suspensions containing: atorvastatin 1.0 mg/kg; H. dulcis extract at 50.0 and 
100.0 mg/kg and dihydromyricetin at 25.0 and 50.0 mg/kg vehicle (control group). The following 
biochemical markers were evaluated; total cholesterol, HDL-C, LDL-C, triglycerides, AST, ALT, and 
alkaline phosphatase. The hypercholesterolemic diet was effective in inducing hypercholesterolemia, 
increasing total cholesterol by 112.7% relative to the control group. The treatments with two doses 
of the extract proved to be promising hypocholesterolemic agents, as they were able to substantially 
reduce total cholesterol and LDL-C, without significantly altering triglycerides, hepatic transaminases, 
and alkaline phosphatase, thereby encouraging the studies with the plant H. dulcis. The groups treated 
with the flavonoid dihydromyricetin, although they showed a significant reduction in total cholesterol 
and LDL-C, and found increases in triglycerides and hepatic transaminases, which is unwanted in the 
context of hypercholesterolaemia.
Uniterms: Hovenia dulcis/pharmacognosy. Hovenia dulcis/hydroalcoholic extract/ cholesterol reduction. 
Hovenia dulcis/flavonoid dihydromyricetin/cholesterol reduction. Dihydromyricetin/cholesterol 
reduction. Hypercholesterolemia/experimental study. Medicinal plants.
No Brasil, o acidente vascular cerebral e a doença arterial coronariana constituem as principais causas 
de mortalidade cardiovascular, sendo os altos níveis de colesterol LDL um dos principais fatores 
de risco. Nesse contexto, diversos extratos vegetais e substâncias naturais isoladas têm se mostrado 
promissoras como hipocolesterolemiantes. O objetivo do trabalho foi avaliar o potencial do extrato 
hidroalcoólico dos frutos de Hovenia dulcis e do flavonóide diidromiricetina na redução do colesterol 
em ratos hipercolesterolêmicos. Quarenta e dois ratos Wistar machos, foram distribuídos em 7 grupos 
de 6 animais, que receberam dieta suplementada com 1% de colesterol e 0,3% de ácido cólico, à 
exceção do grupo controle, que recebeu ração convencional. Posteriormente, os animais foram tratados 
com suspensões orais contendo: atorvastatina 1,0 mg/kg; extrato de H. dulcis de 50,0 e 100,0 mg/kg;  
diidromiricetina de 25,0 e 50,0 mg/kg e veículo (grupo controle). Avaliaram-se os parâmetros 
bioquímicos: colesterol total, HDL-C, LDL-C, triglicérides, AST, ALT e fosfatase alcalina. A dieta 
hipercolesterolêmica foi efetiva na indução da hipercolesterolemia, aumentando o colesterol total em 
112,7% em relação ao controle. Os tratamentos com as duas doses do extrato mostraram-se promissores 
como agentes hipocolesterolemiantes, já que foram capazes de reduzir substancialmente o colesterol 
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total e LDL-C, sem alterar significativamente triglicérides, as transaminases hepáticas e a fosfatase 
alcalina, incentivando, assim, a continuidade de estudos com a planta H. dulcis. Já os grupos tratados 
com o flavonóide diidromiricetina, apesar de apresentarem redução significativa do colesterol total e de 
LDL-C, apresentaram elevações nos triglicérides e nos parâmetros hepáticos, resultado indesejável no 
âmbito das hipercolesterolemias.
Unitermos: Hovenia dulcis/farmacognosia. Hovenia dulcis/extrato hidroalcoólico/redução do colesterol. 
Hovenia dulcis/flavonóide diidromiricetina/redução do colesterol. Diidromiricetina/redução do colesterol. 
Hipercolesterolemia/estudo experimental. Plantas medicinais.
INTRODUCTION
In Brazil, the latest DATASUS data showed that 
stroke and coronary artery disease are the leading causes 
of cardiovascular mortality. The IV Brazilian Guidelines 
on Dyslipidemia and Atherosclerosis Prevention 
(2007) points out that the relative risk of cardiovascular 
events increases with various risk factors, including 
hypercholesterolemia (blood cholesterol levels greater 
than 200 mg/dL).
Several studies consider high levels of LDL 
cholesterol as an important risk factor of coronary 
artery disease and cardiovascular disease in different 
populations. (Khoo et al., 2013; Tonelli et al., 2013; 
Schaefer et al., 2013).
According to the IV Brazilian Guidelines on 
Dyslipidemia and Atherosclerosis Prevention of the 
Society of Cardiology (2007), there has been a decline 
in mortality from cardiovascular causes in developed 
countries in the past 30 years. However, in developing 
countries, including Brazil, there has been a relatively 
rapid and substantial increase.
Studies have shown that plant extracts containing 
antioxidants or isolated compounds capable of reversing 
oxidative stress present in hypercholesterolemia can be 
promising as adjuvant therapy (Negi, Kaur, Dey, 2013; 
Dai et al., 2013; Al-Rejaie et al., 2013).
The effect of antioxidants on hypercholesterolemia 
are attributed to their capacity of increasing the LDL-C 
resistance to oxidation and, therefore, to reduce the risk 
of cardiovascular disease. In vitro studies showed that the 
LDL oxidation only starts after the oxidative stress has 
depleted the contents of cellular antioxidants (Jessup et 
al., 1990).
Hovenia dulcis is popularly known in Brazil mainly 
by “uva-do-japão” (Japanese Raisintree in English) 
(Carvalho, 1994). This species is used in traditional 
Chinese and Korean medicine for alcohol detoxification 
(Chen et al., 2006; Fang et al., 2007; Hase et al., 1997) 
and as a hypoglycemic agent (Jeong-sang, Chang-soo, 
Jong-bang, 2005; Ji et al., 2002; Lee, Chae, Moon, 2005).
The Provital Group (2006) published results 
from in vitro and in vivo studies demonstrating the 
effectiveness of Myriceline® (Dihydromyricetin) to 
reduce cellulite in the skin. The in vitro assays detected 
action of dihydromyricetin on adipogenesis, lipolysis and 
lipogenesis.
Fang et al. (2007) reported high levels of phenolic 
compounds in the alcoholic extract of H. dulcis fruits. 
They also found high antioxidant activity using the 
DPPH method, and related this activity to the phenolic 
compounds present in the extract, mainly to flavonoids. 
Zhang et al. (2003) demonstrated that dihydromyricetin 
has high DPPH (1,1-diphenyl-2-picrylhydrazyl)-radical 
scavenging activity and strong inhibitory action of lipid 
peroxidation.
The induction of hypercholesterolemia in rats is 
widely used. In the study of Yokozawa et al. (2006), 
a diet supplemented with 1% cholesterol and 0.5% 
cholic acid led to increases of 65.7% and 80% in the 
rates of total cholesterol and LDL, respectively, in rats. 
However, Machado et al. (2003) obtained moderate 
hypercholesterolemia (49%) using a diet supplemented 
with 1% cholesterol and 0.1% cholic acid. Afonso et 
al. (2013), using a diet containing 0.5% cholesterol 
and 0.25% cholic acid reached an extreme state of 
hypercholesterolemia with an increase of 297% in total 
cholesterol.
However, up to date, no studies have been 
found that have investigated the hypocholesterolemic 
activity of the plant or the flavonoid dihydromyricetin. 
Nevertheless, studies from our research group (Alvarenga, 
2008) evaluating the effect of H. dulcis extract and 
dihydromyricetin on alloxan-induced diabetic rabbits 
showed, among other results, reduction in total cholesterol 
and LDL-C and increase in HDL-C, suggesting the need 
to study the plant and the flavonoid on a specific model of 
hypercholesterolemia.
The objective of this study was to evaluate the 
potential of the hydroalcoholic extract of the fruit of H. 
dulcis and of dihydromyricetin in cholesterol reduction in 
hypercholesterolemic rats.
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MATERIAL AND METHODS
Processing of plant material
H. dulcis fruits were collected from an adult 
tree, located in the city of Perdões, Minas Gerais State, 
Brazil (21º05´38.51´´S and 45º05´24.75´´) in January 
2009. Exsiccate was deposited in the José Badini-UFOP 
Herbarium (OUPR 21003). The fruits were dried in an 
oven with forced air ventilation at 40 ºC to a constant 
weight, ground and remacerated in ethanol/water 1:1, 
until the material was exhausted (Sonaglio et al., 2004). 
The obtained extract was dried in a rotary evaporator at 
reduced pressure and subsequently lyophilized, then stored 
in an ultrafreezer (-80 ºC).
Test suspensions
An inert  suspension (vehicle) was used to 
incorporate the principal additives of atorvastatin, 
dihydromyricetin synthetic (Provital group®, lot 501435) 
and lyophilized hydroalcoholic H. dulcis extract in their 
respective dosages. The composition of the vehicle was: 
Propilenoglicol (20%); suspending agent Suspender® 
(1.5%); perservatives Nipagim (0.1%) / Nipasol (0.05%) 
and distilled water q.s.p. 100%.
Feeding protocol
The commercial rodent diet (Presence®) was ground 
in a hammer mill, at 3200 rpm, with a 0.25 mm sieve 
(Inbramaq). A portion of the pulverized commercial food 
was reserved for the control diet. 
Simultaneously, cholesterol (Vetec®, lot 1101904) 
and cholic acid (Sigma-Aldrich®, lot 031M1781V) 
were weighed in quantities sufficient for final product 
content of 1.0% of the former and 0.3% of the latter. The 
additives were mixed manually into the pulverized diet 
by geometric dilution. Afterward, the mixture was placed 
in a mixer for 15 minutes for further homogenization. 
The mixture was then placed in an Imbramaq MX-40 
extruder/pelletizer under the following settings: 
supply velocity of 20 kg/h; humidity of 10ccH2O/cm3; 
cutting frequency 32.5 Hz; matrix of 5 mm in diameter, 
maximum temperature of 50 ºC for pellet confection. 
Pellets were dried in an Inbramaq horizontal drier at 
50 ºC. After cooling, the pellets were packaged into 
waterproof plastic bags. The pulverized control diet was 
processed with the same pelletization procedure and 
dried as already described, in order to have the same 
physical and chemical characteristics and digestibility 
of the hypercholesterolemic diet.
Experiments in vivo
The in vivo evaluation of pharmacological activity 
was based on the studies of Machado et al. (2003) and 
Afonso et al. (2013). The use of laboratory animals in this 
study was previously approved by the Ethics Committee 
on Animal Experimentation of the Biological Sciences 
and Health Faculty (FACISA-Viçosa/MG, Protocol 
0017/2012-1).
Forty two (42) male rats (Rattus novergicus, var.
albinus) of the Wistar lineage, approximately 5 weeks 
old, weighing an average of 138.7 ± 11.85 g, were 
acquired from the Vivarium for Animal Experimentation 
of the Veterinary Medicine Department of the Federal 
University of Viçosa and distributed randomly among 
7 groups of 6 animals, housed in cages with an air exhaust 
system, temperature of 22 ± 5 ºC, and relative humidity of 
55 ± 10% and light/dark cycle of 12 hours.
After a habituation period of 5 days, during 
which the animals ingested the control diet (non-
hypercholesterolemic) ,  the animals received a 
hypercholesterolemic diet over the next 10 days (with 
the exception of group 1 which remained on the control 
diet). Starting on the 11th day, treatment began with the test 
substances and the animals maintained the same diet until 
TABLE I - Experimental groups
GROUPS CODE TREATMENT
Group 1 C  Control diet, treated with inert vehicle.
Group 2 HC Hypercholesterolemic diet, treated with inert vehicle.
Group 3 ATOR Hypercholesterolemic diet, treated with atorvastatin 1.0 mg/kg.
Group 4 DHM 1 Hypercholesterolemic diet, treated with dihydromyricetin 25.0 mg/kg.
Group 5 DHM 2 Hypercholesterolemic diet, treated with dihydromyricetin 50.0 mg/kg.
Group 6 EHD 1 Hypercholesterolemic diet, treated with H. dulcis extract 50.0 mg/kg.
Group 7 EHD 2 Hypercholesterolemic diet, treated with H. dulcis extract 100.0 mg/kg.
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day 30. The compounds tested were delivered by gavage 
in 0.5 mL, daily at 6:00 pm.
Euthanasia and biochemical dosages
The animals  were  euthanized in  a  carbon 
dioxide chamber (40% in atmospheric air under slow 
administration). The animals were then immediately 
subject to cardiac perfusion for blood collection. Using the 
animals’ serum, biochemical dosages were analyzed with a 
Cobas Mira Plus (Roche®) instrument. The concentrations 
of total cholesterol (COT), triglycerides (TG) and serum 
high density lipoprotein (HDL-C) were determined by 
enzymatic colorimetric analysis, using a biochemical 
kit for each respective analysis. Low density lipoprotein 
(LDL-C) was calculated according to the formula LDL= 
COT - HDL - (TG/5), as described by Friedwald, Levy and 
Fradrickson (1972). Concentrations of aminotransferase 
alanine (ALT), aspartatoaminotransferase (AST), and 
alkaline phosphatase (FALC) were determined by the 
kinetic method using a biochemical kit.
Statistical analysis
Analysis of variance (ANOVA), was calculated, 
followed by a Dunnett test with a level of significance set 
at p<0.05, using group HC as the reference group, using 
the program SAEG 9.1.
RESULTS AND DISCUSSION
Induction of hypercholesterolaemia
A diet supplemented with 1.0% cholesterol and 
0.3% cholic acd, for a period of 30 days, was capable of 
significantly inducing hypercholesterolemia, with observed 
increases found in serum levels of total cholesterol (COT) 
(82.66 ± 10.11mg/dL vs 175.83 ± 6.24 mg/dL) and low 
density lipoprotein (LDL) (30.53 ± 8.95 mg/dL vs 125.16 ± 
24.19 mg/dL) along with a reduction in serum levels of 
high density lipoprotein (HDL) (43.66 ± 2.16 mg/dL 
vs 35.5 ± 8.21 mg/dL) compared to the control group. 
Higher results were found by Afonso et al. (2013), who 
employed a diet supplemented with 0.5% cholesterol and 
0.25% cholic acid over a period of 30 days in Wistar rats, 
for which there was an increase of 297.9%, while in the 
present study an elevation of 112.7% was observed for 
the same parameter. On the other hand, in a study done 
by Yokozawa et al. (2006) a diet supplemented with 1% 
cholesterol and 0.5% cholic acid showed only a 65.7% 
increase of total cholesterol. There was no significant 
difference between food consumption and weight gain by 
Analysis of variance(Tables II and III).
Lipid profile
Table IV shows the average values of analyzed 
biochemical parameters for the experimental groups on 
day 30, with their respective significant statistics.
Total cholesterol
All treatments significantly reduced levels of total 
cholesterol (Dunnett, p<0.05) compared to reference 
group HC, with the largest reduction being seen in the 
group treated with atorvastatin 1.0 mg/kg, at 40.38%. 
Groups EHD 1 and EHD 2 had reductions of 22.56 and 
33.36%, respectively. Also, the groups treated with the 
flavonoid (DHM 1 and DHM 2) had a reduction of 19.46 
and 17.53%, respectively. It is worthy to note, however, 
that the doses of the extract and the flavonoid were 
higher than the medical reference dose of atorvastatin, 
with the superiority of this substance over the others 
being unquestionable regarding the reduction of total 
cholesterol.
In the study of Alvarenga (2008), the hydroalcoholic 
extract of H. dulcis at a dose of 200 mg/kg reduced total 
cholesterol in diabetic rabbits by 68% over 28 days. It is 
TABLE II - Mean of weight of animals in grams
Groups Inicial Weight First week Second Week Third Week Fourth Week
C 149.2 159.2 176.7 200.8 229.2
HC 134.2 154.2 171.7 198.3 235.0
ATOR 135.0 150.0 161.7 189.2 220.8
DHM 1 140.0 156.7 171.7 199.2 225.0
DHM 2 133.3 154.2 165.8 195.0 218.3
EHD 1 143.3 163.3 180.0 204.2 230.0
EHD 2 135.8 155.0 166.7 194.2 216.7
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TABLE III - Mean of Food Consumption of animals in grams
Groups First week Second Week Third Week Fourth Week
C 12.1 14.0 15.8 18.3
HC 11.6 13.8 16.0 18.3
ATOR 12.5 14.3 16.1 18.1
DHM 1 11.8 13.5 16.3 18.8
DHM 2 12.4 14.3 15.7 17.5
EHD 1 12.1 14.2 16.5 19.0
EHD 2 13.2 14.7 15.7 17.8
TABLE IV- Intergroup average values ± standard deviation for total cholesterol, (COT), triglycerides (TG), HDL cholesterol 
(HDL-C) and LDL cholesterol (LDL-C)
Groups COT (mg/dL) TG (mg/dL) HDL-C (mg/dL) LDL-C (mg/dL)
C 82.66 ±10.11 * 42.33 ± 7.22 43.66±2.16 30,53± 8.95*
HC 175.83±16.24 75.83±43.77 35.5± 8.21 125.16± 24.19
ATOR 104.83±15.14 * 48.66± 12.94 56.66± 21.13 * 39.80±18.78*
DHM 1 141.66±22.79* 128.00± 50.39 * 48.17± 11.03 67.90± 13.96*
DHM 2 145.00±28.44* 105.00± 34.97 45.5± 2.07 78.50± 28.32*
EHD 1 136.16±21.46* 96.16± 50.75 42.83± 7.16 74.10± 33.23*
EHD 2 117.16±24.33* 74.16±20.09 41.66± 7.44 60.66±29.88*
Values marked with an asterisk (*) in the table differ from group HC at a significance level of 95% (p<0.05) compared using 
Dunnett’s test.
possible to infer that the flavonoid dihydromyricetin has 
hypocholesterolemic action, but is not the only active 
factor present in the extract, since administering the extract 
in a dose of 50.0 mg/kg exhibited a greater reduction than 
administering the isolated flavonoid at the same dose, 
indicating the presence of additive synergism between 
molecules in the extract.
It is known that saponins form insoluble complexes 
with β-hydroxysteroids, diminishing intestinal absorption 
of cholesterol and increasing the fecal excretion of sterols 
(Milgate, Roberts, 1995). In H. dulcis, the presence of 
saponins in leaves extract were describe by Hogihara et 
al. (1987) and hydroalcoholic extract of H. dulcis fruits 
were describe by Alvarenga (2008). It is still necessary 
further studies to determine presence of saponins 
in H. dulcis and confirm its hypocholesterolemic 
action.
LDL-C
All treatments significantly reduced levels of LDL-C 
(Dunnett, p<0.05) compared to reference group HC, 
with the largest reduction being in the group treated with 
atorvastatin 1.0 mg/kg, at 68.20%. The groups EHD 1 and 
EHD 2 had reductions of 40.79 and 51.53%, respectively. 
Also, groups DHM 1 and DHM 2 had reductions of 45.57 
and 37.28%, respectively.
Several mechanisms of action of flavonoids on lipid 
metabolism have been described. Kothari et al. (2011) 
reported the increased fecal excretion of cholesterol in 
hypercholesterolemic rats treated with fresh Triticum 
aestivum (wheat) grass juice.
Quesada et al. (2009) reported that grape seed 
proanthocyanidins repress genes controlling lipogenesis 
and VLDL assembling in liver in rats fed high fat diet. 
Another mechanism involving transcriptional regulation 
was described by Goldwasser et al. (2010), which studied 
the benefits of the flavonoid naringenin on hepatic lipid 
metabolism in rats.
Brutieridin and melitidin, flavonoids of bergamot 
juice are structural analogues of statins and were shown 
to inhibit HMG-CoA reductase the enzyme that catalyzes 
conversion of HMG-CoA to mevalonate, which is the 
rate limiting step in the cholesterol synthesis pathway 
(Leopoldini et al., 2010).
The LDL cholesterol levels reduction is extremely 
important in hypercholesterolaemic individuals, because 
elevated plasma levels of LDL are highly associated with 
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appearance of coronary artery disease (Hankey, 2002; 
Giribela, 2007).
HDL-C
The only group ATOR showed a statistically 
significant rise (Dunnett, p<0.05). Auger et al. (2002) 
also had similar results when they evaluated the effects 
of phenolic compounds present in red wine on plasma 
lipids in hypercholesterolaemia hamsters. A significant 
difference was not found between HDL-C levels of treated 
and control animals. The same occurred in the work of 
Hirunpanich et al. (2006) while working with hibiscus 
and Soares et al. (2005) with ginger, white mulberry and 
rosemary in hypercholesterolemic rats.
Although treatments for groups DHM 1, DHM 2, 
EHD 1 and EHD 2 did not generate a significant rise in 
HDL cholesterol, it is worth noting that the reduction 
in levels of total cholesterol and LDL cholesterol under 
circulation also represents an essential step in the 
prevention of cardiovascular disease (Lecumberri et al., 
2007).
Triglycerides
Only group DHM 1 differentiating itself statistically, 
showing a significantly elevated value for this parameter 
(Dunnett p<0.05).
According to the IV Brazilian Guidelines on 
Dyslipidemia and Prevention of Atherosclerosis (2007), 
accumulation of chylomicrons and VLDL in the plasma 
compartment results in hypertriglyceridemia and stems from 
a decrease in triglyceride hydrolysis of these lipoproteins 
by lipoprotein lipase or from increased synthesis of VLDL, 
since these lipoproteins are rich in triglycerides.
Given the above, we postulate that treatment with 
DHM 1 (dose of 25.0 mg/kg) produced a negative result 
within the context of hypercholesterolemias, as although 
there was a significant reduction in total cholesterol and 
LDL-c, the treatment promoted a significant increase in 
triglycerides.
In Afonso et al. (2013), an aqueous extract of 
rosemary at a concentration of 70 mg/kg was able to 
significantly reduce levels of total cholesterol (39.8%) and 
LDL-c (45.6%), but positive effects for triglycerides and 
HDL-C were not observed.
Cherem et al. (2007) subjected guinea pigs to a high-
fat diet with and without the addition eggplant peels, and 
their study showed a reduction in levels of total cholesterol 
and LDL-cholesterol, at 45 and 54%, respectively. A 
positive effect on triglycerides levels was not observed.
AST, ALT and alkaline phosphatase
As the liver is considered the main organ responsible 
for the maintenance of cholesterol homeostasis, the 
activity of enzymes indicative of liver lesions, alanine 
aminotransferase and aspartate aminotransferase, was 
determined (see Table V).
Values marked with an asterisk (*) in the table, differ 
from group HC, at a significance level of 95% (p<0.05), 
when compared using Dunnett’s test.
The results show a significant increase in ALT for the 
group treated with dihydromyricetin at a dose of 25.0 mg/
kg. Nevertheless, we observed that the group treated with 
a larger dose of dihydromyricetin (50.0 mg/kg) did not 
show this profile. Such a result can indicate hepatotoxicity 
or could be attributed to a rise in total lipids, especially 
triglycerides, a parameter significantly augmented in this 
group.
The hepatoprotective action of Hovenia dulcis has 
been a focus of other studies. Hase et al. (1997) found 
liver-protecting action of H. dulcis fruits methanolic 
extract, acting on CCl4 toxicity induced in rats and 
D-GalN/LPS in mice. The animals were treated with 100 
mg/kg of extract twice a week for one week before hepatic 
toxicity induction. Alvarenga (2008) observed a 72% 
reduction of the AST over 28 days, by treating diabetic 
rabbits with H. dulcis extract at a 200 mg/kg dose.
In the present study there was no statistically 
significant difference in AST for the groups treated with 
the extract (EHD) compared to the control (Dunnett, 
p<0.05).
In Alkaline Phosphatase, DHM 2 had values 
significantly higher than HC. This suggests the necessity 
of conducting histopathological analysis to investigate 
hepatotoxicity. Alkaline hyperphosphatemia occurs in 
intrahepatic obstruction in hepatocellular carcinoma, 
hepatitis, cirrhosis, and through the effect of various 
TABLE V - Average values ± standard deviation of the parameters 
AST, ALT and Alkaline Phosphatase (FALC)
Groups AST (U/L) ALT (U/L) FALC (U/L)
C 170.8±23.8 47.2±5.1 158.0±20.4
HC 151.5±41.7 45.7±3.9 216,8±30.1
ATOR 130.3±19.8 41.2±8.9 192.2±21.2
DHM 1 156.0±11.1 71.8±28.4 * 259.2±63.1
DHM 2 121.0±20.3 48.2±8.1 341.8±70.7 *
EHD 1 122.0±15.2 56.2±13.8 268.3±28.3
EHD 2 131.8±14.2 53.0±9.9 245.5±40.2
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drugs (antifungals, benzodiazepines, steroids and 
antihypertensives). Its activity can increase two to three 
times during intrahepatic obstruction (Motta, 2003).
CONCLUSIONS
The H. dulcis extract treatments can be promising 
as hypocholesterolemic agents, especially when used 
in higher doses (100.0 mg/kg), with a substantial Total 
Cholesterol and LDL-C reduction of 33.3% and 51.5%. 
There was no increase in the levels of triglycerides and 
HDL-C found in plasma. 
In the dihydromiricetina (25.0 mg/kg) group there 
was a significant increase in triglycerides, which was an 
unwanted result when treating hypercholesterolemia.
Further studies should be encourage to determine 
the exact mechanism of action and toxicity of the 
H. dulcis extract and its pharmacological effects in 
hypercholesterolemia, so it could be safely used as an 
option in the future. 
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